Book contents
- Frontmatter
- Contents
- Foreword
- Preface
- Acknowledgements
- Abbreviations
- 1 Epidemiological considerations
- 2 The clinical spectrum of ALS
- 3 The pathology of ALS
- 4 Pathogenic mechanisms in ALS
- 5 The role of clinical neurophysiology in ALS
- 6 The application of imaging techniques
- 7 ALS therapy, therapeutic trials, and neuroprotection
- 8 The overlap syndromes
- References
- Index
Preface
Published online by Cambridge University Press: 25 March 2010
- Frontmatter
- Contents
- Foreword
- Preface
- Acknowledgements
- Abbreviations
- 1 Epidemiological considerations
- 2 The clinical spectrum of ALS
- 3 The pathology of ALS
- 4 Pathogenic mechanisms in ALS
- 5 The role of clinical neurophysiology in ALS
- 6 The application of imaging techniques
- 7 ALS therapy, therapeutic trials, and neuroprotection
- 8 The overlap syndromes
- References
- Index
Summary
In my dreams I climb the mountains high,
In my dreams I face the samurai.
In my dreams I stroke my lover's hair,
In my dreams I travel everywhere.
In my dreams I kiss and never tell,
In my dreams I'm not a languid shell.
In my dreams I never convalesce,
In my dreams I don't have ALS.
Laugh, I Thought I'd Die – My Life With ALS
Dennis Kay, 1993Amyotrophic lateral sclerosis (ALS) research has escalated considerably during this, ‘the decade of the brain’. Frequently read neurological–neuroscience journals contain at least one article related to ALS in virtually each issue. A current Medline search reveals more than 1000 titles relevant to ALS or motoneuron disease (MND). The latter term is still commonly used synonymously with ALS in much of Europe. The Internet too has a growing number of WEB sites devoted to ALS, but one in particular (http://http1.brunel.ac.ukö8080/ ∼ hssrsdn/alsig/alsig.htm) has a weekly digest that maintains much current information of interest to patients, their care-givers and professionals. The subcommittee on ALS and Motoneuron Diseases of the World Federation on Neuromuscular Diseases, a standing committee of the World Federation of Neurology, has substantially expanded its activities. In the last four years, the committee has developed the first formal classification of ALS, criteria and valid end-points for therapeutic trials and a worldwide consortium directed towards the collaborative performance of therapeutic trials.
- Type
- Chapter
- Information
- Amyotrophic Lateral SclerosisA Synthesis of Research and Clinical Practice, pp. xiii - xivPublisher: Cambridge University PressPrint publication year: 1998